AbbVie Inc
4AB.STU
Exchange: | STU |
Currency | Euro |
ISIN: | US00287Y1091 |
LEI: | FR5LCKFTG8054YNNRU85 |
Primary Ticker: | ABBV.US |
Fiscal Year End: | December |
Updated On: | 2024-11-03 |
Highlights
Market Capitalization: | 196410270741 |
Market Capitalization Mln: | 196410.27 |
PEG Ratio: | 0.47 |
Dividend Yield: | 0.06 |
Most Recent Quarter: | 2024-06-30 |
Gross Profit TTM: | 21530000000 |
Valuation
Forward PE: | 17.09 |
Price Sales TTM: | 6.55 |
Price Book MRQ: | 53.46 |
Enterprise Value: | 383146207901 |
Enterprise Value Revenue: | 7.50 |
Enterprise Value Ebitda: | 44.78 |
Technicals
52 Week High: | 190.24 |
52 Week Low: | 120.59 |
50 Day MA: | 176.19 |
200 Day MA: | 163.54 |
Splits & Dividends
Forward Annual Dividend Yield: | 0.06 |
Earnings
Report Date: | 2025-07-23 |
Date: | 2025-06-30 |
Before After Market: | After Market |
Currency: | USD |
Report Date: | 2025-04-24 |
Date: | 2025-03-31 |
Before After Market: | After Market |
Currency: | USD |
Report Date: | 2025-01-31 |
Date: | 2024-12-31 |
Before After Market: | After Market |
Currency: | USD |
Report Date: | 2024-10-30 |
Date: | 2024-09-30 |
Before After Market: | After Market |
Currency: | USD |
Date: | 2024-09-30 |